| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |